Hall Christopher M

Track

Insider profile

Performance

Overall performance
2.6
Performance over holding periods
2.6
30 days 90 days 120 days
Average return -2% 8.2% 15.1%
Success rate 33% 68% 82%
Transactions
3 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Hall Christopher M's trades of Personalis Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Planned sale
Price
361.24
Quantity 611 -28.5%
Value US$4,016,242
Transaction date
Proposed sale
Price
30.69
Quantity 72,856
Value US$4,439,605
Transaction date
Planned sale
Price
259.69
Quantity 19,172 +26.7%
Value US$1,744,315
Transaction date
Proposed sale
Price
12.59
Quantity 100,000
Value US$1,259,000
Transaction date
Planned sale
Price
11.02
Quantity 80,091 -25.3%
Value US$882,603
Transaction date
Planned sale
Price
11.02
Quantity 19,909 -7.8%
Value US$219,397
Transaction date
Proposed sale
Price
9.49
Quantity 100,000
Value US$949,000
Transaction date
Sale
Price
8.99
Quantity 29,612 -16.6%
Value US$266,212
Transaction date
Sale
Price
5.38
Quantity 26,443 -12.9%
Value US$142,263
Transaction date
Sale
Price
0.93
Quantity 20,459 -9.1%
Value US$19,027
US Veracyte Inc (VCYT)
Transaction date
Planned sale
Price
25.44
Quantity 86,220 -75.0%
Value US$2,193,273
US Veracyte Inc (VCYT)
Transaction date
Planned sale
Price
24.72
Quantity 28,780 -20.0%
Value US$711,442
US Veracyte Inc (VCYT)
Transaction date
Planned sale
Price
25.58
Quantity 4,836 -14.4%
Value US$123,699
US Veracyte Inc (VCYT)
Transaction date
Planned sale
Price
25.09
Quantity 75,164 -69.1%
Value US$1,885,985
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-07-09 2026-07-09
PlS Planned sale
611 -28.5%
361.24
US$4,016,242 		611 -28.5% 361.24 US$4,016,242
2026-07-09 2026-07-09
PrS Proposed sale
72,856
30.69
US$4,439,605 		72,856 30.69 US$4,439,605
2026-06-26 2026-06-26
PlS Planned sale
19,172 +26.7%
259.69
US$1,744,315 		19,172 +26.7% 259.69 US$1,744,315
2026-06-26 2026-06-26
PrS Proposed sale
100,000
12.59
US$1,259,000 		100,000 12.59 US$1,259,000
2026-05-29 2026-05-29
PlS Planned sale
80,091 -25.3%
11.02
US$882,603 		80,091 -25.3% 11.02 US$882,603
2026-05-29 2026-05-28
PlS Planned sale
19,909 -7.8%
11.02
US$219,397 		19,909 -7.8% 11.02 US$219,397
2026-05-28 2026-05-28
PrS Proposed sale
100,000
9.49
US$949,000 		100,000 9.49 US$949,000
2025-11-05 2025-11-03
S Sale
29,612 -16.6%
8.99
US$266,212 		29,612 -16.6% 8.99 US$266,212
2024-11-05 2024-11-01
S Sale
26,443 -12.9%
5.38
US$142,263 		26,443 -12.9% 5.38 US$142,263
2023-11-03 2023-11-01
S Sale
20,459 -9.1%
0.93
US$19,027 		20,459 -9.1% 0.93 US$19,027
2019-05-08 2019-05-06
US Veracyte Inc (VCYT)
PlS Planned sale
86,220 -75.0%
25.44
US$2,193,273 		86,220 -75.0% 25.44 US$2,193,273
2019-05-08 2019-05-06
US Veracyte Inc (VCYT)
PlS Planned sale
28,780 -20.0%
24.72
US$711,442 		28,780 -20.0% 24.72 US$711,442
2019-04-12 2019-04-11
US Veracyte Inc (VCYT)
PlS Planned sale
4,836 -14.4%
25.58
US$123,699 		4,836 -14.4% 25.58 US$123,699
2019-04-12 2019-04-11
US Veracyte Inc (VCYT)
PlS Planned sale
75,164 -69.1%
25.09
US$1,885,985 		75,164 -69.1% 25.09 US$1,885,985